Head-To-Head Review: Avivagen (OTCMKTS:VIVXF) and High Tide (NASDAQ:HITI)

High Tide (NASDAQ:HITI) and Avivagen (OTCMKTS:VIVXF) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

Earnings & Valuation

This table compares High Tide and Avivagen”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
High Tide	$425.10 million	0.46	-$36.23 million	($0.34)	-6.59
Avivagen	N/A	N/A	N/A	($0.04)	N/A

Avivagen has lower revenue, but higher earnings than High Tide. High Tide is trading at a lower price-to-earnings ratio than Avivagen, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares High Tide and Avivagen’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
High Tide	-7.53%	0.58%	0.24%
Avivagen	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of current ratings and price targets for High Tide and Avivagen, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
High Tide	1	0	3	1	2.80
Avivagen	0	0	0	0	0.00

High Tide currently has a consensus target price of $6.13, indicating a potential upside of 173.44%. Given High Tide’s stronger consensus rating and higher possible upside, analysts clearly believe High Tide is more favorable than Avivagen.

Insider and Institutional Ownership

4.5% of High Tide shares are held by institutional investors. 12.4% of High Tide shares are held by insiders. Comparatively, 2.1% of Avivagen shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

High Tide beats Avivagen on 9 of the 11 factors compared between the two stocks.

About High Tide

High Tide Inc. engages in the cannabis retail business in Canada, the United States, and internationally. The company operates through Retail and Wholesale segments. It operates licensed retail cannabis stores; and provides data analytics services. In addition, the company manufactures and distributes consumption accessories. Further, it sells its products through online sales via e-commerce platform. The company offers its products under the Daily High Club, DankStop, FABCBD, GC, Nuleaf, Smoke Cartel, and Blessed CBD brands. The company was formerly known as High Tide Ventures Inc. and changed its name to High Tide Inc. in October 2018. High Tide Inc. was founded in 2009 and is headquartered in Calgary, Canada.

About Avivagen

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.